Laura Perkins
About
Laura Perkins is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Laura Perkins has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 17 papers in Cardiology and Cardiovascular Medicine and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura Perkins's work include Coronary Interventions and Diagnostics (31 papers), Cardiac Valve Diseases and Treatments (9 papers) and Aortic aneurysm repair treatments (9 papers). Laura Perkins is often cited by papers focused on Coronary Interventions and Diagnostics (31 papers), Cardiac Valve Diseases and Treatments (9 papers) and Aortic aneurysm repair treatments (9 papers). Laura Perkins collaborates with scholars based in United States, Netherlands and United Kingdom. Laura Perkins's co-authors include David E. Swayne, Renu Virmani, Richard Rapoza, Larry Scherwitz, Margaret A. Chesney, Gwenda Hughes, Marika Kamberi, Alexander Sheehy, Patrick W. Serruys and Yoshinobu Onuma and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Virology.
In The Last Decade
Laura Perkins
55 papers receiving 2.0k citations
Peers
Laura Perkins
Jean‐François Toussaint France
Daniel J. O’Brien United States
Thomas S. Thornhill United States
Elizabeth A. Miller United States
Gregory Engel United States
Zane A. Brown United States
Ragnvi Hagman Sweden
Russell A. Williams United States
Corinne R. Sweeney United States
Francesco De Seta Italy
Citations per year, relative to Laura Perkins Laura Perkins (= 1×)
peers
Jean‐François Toussaint
Countries citing papers authored by Laura Perkins
Since
Specialization
Citations
This map shows the geographic impact of Laura Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Perkins more than expected).
Fields of papers citing papers by Laura Perkins
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Laura Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Perkins. The network helps show where Laura Perkins may publish in the future.
Co-authorship network of co-authors of Laura Perkins
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Perkins. A scholar is included among the top collaborators of Laura Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Perkins. Laura Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zhang, Shumin, Chantal E. Holy, Gary Eichenbaum, et al.. (2021). Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies. Regulatory Toxicology and Pharmacology. 125. 104987–104987.
2.
Monnot, Andrew D., Michael Kovochich, Jared Wilsey, et al.. (2021). A hazard evaluation of the reproductive/developmental toxicity of cobalt in medical devices. Regulatory Toxicology and Pharmacology. 123. 104932–104932.
3.
Jinnouchi, Hiroyuki, Matthew Kutyna, Sho Torii, et al.. (2021). Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents. EuroIntervention. 17(3). 248–256.
4.
Sato, Yu, Hiroyuki Jinnouchi, Frank D. Kolodgie, et al.. (2020). TCT CONNECT-250 Comparison of Thromboresistance of Everolimus-Eluting Fluoropolymer Stents and Competitive Drug-Eluting Stents Between Aspirin and Clopidogrel Single Antiplatelet Therapy Using an Ex Vivo Swine Shunt Model and Evaluation of a Novel Flow Loop Model Under Aspirin Single Antiplatelet Therapy. Journal of the American College of Cardiology. 76(17). B110–B111.
5.
Jinnouchi, Hiroyuki, Frank D. Kolodgie, Qi Cheng, et al.. (2019). TCT-291 Comparison of Thromboresistance Between Everolimus-Eluting Fluoropolymer Stent and Currently Available Drug-Eluting Stent in an Ex Vivo Swine Shunt Model Under Only Single Antiplatelet Therapy. Journal of the American College of Cardiology. 74(13). B290–B290.
6.
Torii, Sho, Qi Cheng, Hiroyoshi Mori, et al.. (2019). Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents. EuroIntervention. 14(16). 1685–1693.
7.
Cheng, Yanping, Jinggang Xia, Paweł Gąsior, et al.. (2016). TCT-833 Late Lumen Gain with Bioresorbable Vascular Scaffold in the Porcine Model of Spontaneous Untreated Atherosclerosis: a 3-year IVUS and OCT Study. Journal of the American College of Cardiology. 68(18). B337–B337.
8.
Kossuth, Mary Beth, Laura Perkins, & Richard Rapoza. (2016). Design Principles of Bioresorbable Polymeric Scaffolds. Interventional Cardiology Clinics. 5(3). 349–355.
9.
Campos, Carlos M., Yuki Ishibashi, Jeroen Eggermont, et al.. (2015). Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model. International journal of cardiac imaging. 31(3). 471–482.
10.
Nakatani, Shimpei, Yoshinobu Onuma, Yuki Ishibashi, et al.. (2014). Temporal Evolution of Strut Light Intensity After Implantation of Bioresorbable Polymeric Intracoronary Scaffolds in the ABSORB Cohort B Trial. Circulation Journal. 78(8). 1873–1881.
11.
Vorpahl, Marc, Masataka Nakano, Laura Perkins, et al.. (2014). Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model. EuroIntervention. 10(7). 833–841.
12.
Gogas, Bill D., Maria Radu, Yoshinobu Onuma, et al.. (2011). Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies. International journal of cardiac imaging. 28(3). 499–511.
13.
Onuma, Yoshinobu, Nieves Gonzalo, Evelyn Regar, et al.. (2010). INTRACORONARY OPTICAL COHERENCE TOMOGRAPHY (OCT) AND HISTOLOGY 2, 3 AND 4 YEARS AFTER IMPLANTATION OF BIORESORBABLE EVEROLIMUS-ELUTING STENTS IN A PORCINE CORONARY MODEL: AN ATTEMPT TO DECIPHER THE HUMAN OCT IMAGES IN THE ABSORB TRIAL. Journal of the American College of Cardiology. 55(10). A217.E2057–A217.E2057.
14.
Turpin, Elizabeth A., Laura Perkins, & David E. Swayne. (2002). Experimental Infection of Turkeys with Avian Pneumovirus and Either Newcastle Disease Virus or Escherichia coli. Avian Diseases. 46(2). 412–422.
15.
Perkins, Laura, et al.. (1998). Value of markers of myocardial injury and intracoronary thrombus in risk stratification of patients presenting to an emergency department with chest pain. Journal of the American College of Cardiology. 31. 91–91.
16.
Mohler, Emile R., Thomas Ryan, Douglas S. Segar, et al.. (1998). Clinical utility of troponin T levels and echocardiography in the emergency department. American Heart Journal. 135(2). 253–260.
17.
Dyer, Alan R., et al.. (1992). Random Digit Dialing in Chicago CARDIA: Comparison of Individuals with Unlisted and Listed Telephone Numbers. American Journal of Epidemiology. 135(6). 697–709.
18.
Winkler, Carey L., John K. Tucker, John C. Hauth, et al.. (1991). Histocompatibility Antigen Subtypes in Black Women with Class A1or Class GB Diabetes Mellitus. American Journal of Perinatology. 8(2). 106–109.
19.
Tucker, John K., Carey L. Winkler, John C. Hauth, et al.. (1991). Autoantibodies in Black Women with Class A1or Class GB Diabetes Mellitus. American Journal of Perinatology. 8(2). 103–105.
20.
Windsor, Richard A., et al.. (1989). Sensitivity, specificity and predictive value of saliva thiocyanate among pregnant women. Addictive Behaviors. 14(4). 447–452.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jean‐François Toussaint Breakdown of academic impact, for papers by Daniel J. O’Brien Breakdown of academic impact, for papers by Thomas S. Thornhill Breakdown of academic impact, for papers by Elizabeth A. Miller Breakdown of academic impact, for papers by Gregory Engel Breakdown of academic impact, for papers by Zane A. Brown Breakdown of academic impact, for papers by Ragnvi Hagman Breakdown of academic impact, for papers by Russell A. Williams Breakdown of academic impact, for papers by Corinne R. Sweeney Breakdown of academic impact, for papers by Francesco De Seta